Literature DB >> 28276831

Pancreatic cancer stroma: controversies and current insights.

Daniel Ansari1, Maria Carvajo1, Monika Bauden1, Roland Andersson1.   

Abstract

Pancreatic cancer is characterized by a dense stromal response. The stroma includes a heterogeneous mass of cells, including pancreatic stellate cells, fibroblasts, immune cells and nerve cells, as well as extracellular matrix proteins, cytokines and growth factors, which interact with the tumor cells. Previous research has indicated that stromal elements contribute to tumor growth and aggressiveness. However, recent studies suggest that some elements of the stroma may actually restrain the tumor. This review focuses on the complex interactions between the stromal microenvironment and tumor cells, discussing molecular mechanisms and potential future diagnostic and therapeutic approaches by targeting the stroma.

Entities:  

Keywords:  Pancreatic cancer; desmoplasia; microenvironment; stroma; targeted therapy

Mesh:

Substances:

Year:  2017        PMID: 28276831     DOI: 10.1080/00365521.2017.1293726

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  18 in total

Review 1.  The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance.

Authors:  Douglas E Biancur; Alec C Kimmelman
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-04-24       Impact factor: 10.680

2.  TRPC6 channels modulate the response of pancreatic stellate cells to hypoxia.

Authors:  Nikolaj Nielsen; Kateryna Kondratska; Tobias Ruck; Benedikt Hild; Ilya Kovalenko; Sandra Schimmelpfennig; Jana Welzig; Sarah Sargin; Otto Lindemann; Sven Christian; Sven G Meuth; Natalia Prevarskaya; Albrecht Schwab
Journal:  Pflugers Arch       Date:  2017-08-28       Impact factor: 3.657

3.  Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods.

Authors:  Yi Lu; Chujun Li; Honglei Chen; Weijie Zhong
Journal:  Mol Biol Rep       Date:  2018-09-01       Impact factor: 2.316

Review 4.  Targeting TAM to Tame Pancreatic Cancer.

Authors:  Mitchell S von Itzstein; Michael C Burke; Rolf A Brekken; Todd A Aguilera; Herbert J Zeh; Muhammad Shaalan Beg
Journal:  Target Oncol       Date:  2020-10       Impact factor: 4.493

Review 5.  Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment.

Authors:  Daniel Ansari; Helmut Friess; Monika Bauden; Johan Samnegård; Roland Andersson
Journal:  Oncotarget       Date:  2018-01-06

6.  Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma.

Authors:  Dingyuan Hu; Daniel Ansari; Krzysztof Pawłowski; Qimin Zhou; Agata Sasor; Charlotte Welinder; Theresa Kristl; Monika Bauden; Melinda Rezeli; Yi Jiang; György Marko-Varga; Roland Andersson
Journal:  Oncotarget       Date:  2018-01-03

Review 7.  The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives.

Authors:  Shun Wang; Yan Zheng; Feng Yang; Le Zhu; Xiao-Qiang Zhu; Zhe-Fang Wang; Xiao-Lin Wu; Cheng-Hui Zhou; Jia-Yan Yan; Bei-Yuan Hu; Bo Kong; De-Liang Fu; Christiane Bruns; Yue Zhao; Lun-Xiu Qin; Qiong-Zhu Dong
Journal:  Signal Transduct Target Ther       Date:  2021-07-05

Review 8.  EMT and Treatment Resistance in Pancreatic Cancer.

Authors:  Nicola Gaianigo; Davide Melisi; Carmine Carbone
Journal:  Cancers (Basel)       Date:  2017-09-12       Impact factor: 6.639

Review 9.  Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer Treatment.

Authors:  Jeffrey Norton; Deshka Foster; Malini Chinta; Ashley Titan; Michael Longaker
Journal:  Cancers (Basel)       Date:  2020-05-25       Impact factor: 6.639

Review 10.  Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance.

Authors:  Priscilla Cascetta; Alessandro Cavaliere; Geny Piro; Lorena Torroni; Raffaela Santoro; Giampaolo Tortora; Davide Melisi; Carmine Carbone
Journal:  Int J Mol Sci       Date:  2018-10-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.